| 发明名称 |
PAN-ELR+ CXC CHEMOKINE ANTIBODES |
| 摘要 |
Antibodies are provided that specifically bind seven human ELR+ CXC chemokines. The antibodies of the invention are useful for treating various inflammatory/autoimmune diseases, such as inflammatory bowel disease (IBD), plaque psoriasis, and palmoplantar pustulosis; and cancer, such as renal cancer or ovarian cancer. |
| 申请公布号 |
TN2015000377(A1) |
申请公布日期 |
2017.01.03 |
| 申请号 |
TN20150000377 |
申请日期 |
2015.08.31 |
| 申请人 |
Eli Lilly and Company |
发明人 |
BEIDLER, Catherine Brautigam;KIKLY, Kristine Kay;STRIFLER, Beth Ann;WITCHER, Derrick Ryan;BOYLES, Jeffrey Streetman |
| 分类号 |
C07K16/18;C07K16/24 |
主分类号 |
C07K16/18 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
